Skip to search formSkip to main contentSkip to account menu

orgotein

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
  • G. Primus
  • International Urology and Nephrology
  • 1993
  • Corpus ID: 23515298
Eighteen patients with Peyronie's disease have been treated with the anti-inflammatory metalloprotein Orgotein, which exhibits a… 
1991
1991
The efficacy of injection of orgotein was compared with that of betamethasone over a one-year period in 419 patients with… 
1984
1984
Thirty-six patients with osteo-arthrosis affecting the knee took part in a randomized double-blind study in which intra-articular… 
1982
1982
: Orgotein was injected into the right intercarpal joint of each of 8 horses; the corresponding left joint was left alone (not… 
Highly Cited
1981
Highly Cited
1981
22 patients with Peyronie's disease have been treated with Orgotein, the new anti-inflammatory metalloprotein which pronounced… 
1981
1981
Twenty-three patients with Peyronie's disease have been treated with the new anti-inflammatory metalloprotein drug orgotein… 
1981
1981
  • W. Huber
  • European journal of rheumatology and inflammation
  • 1981
  • Corpus ID: 39948724
Orgotein is the generic name adopted by the USAN Council for drug versions of the Cu-Zn superoxide dismutases. It is obtained… 
Highly Cited
1978
Highly Cited
1978
In rats, daily administration of subcutaneous dose of 2.5 mg/kg of orgotein, the pharmaceutical preparation of Zn-Cu superoxide… 
1978
1978
SummaryOrgotein, the drug version of Cu-Zn superoxide dismutases is a new and safe anti-inflammatory agent. Animal experiments…